Chantal Raymond | 14/04/2024
You have heard us say it, you have read about it: we are deeply grateful for the work and time and dedication of our volunteers … But have you...
Chantal Raymond | 27/03/2024
It is safe to say that research provides better quality of life and will lead, one day, inevitably to cures. This is why the Canadian Hemophilia Society (CHS) is...
David Page | 22/01/2024
Hamilton, January 22, 2024 – McMaster University, in collaboration with CSL Behring, has announced a new gene therapy trial for etranacogene dezaparvovec (Hemgenix) in hemophilia B. Hemgenix received its...
Chantal Raymond | 27/11/2023
The hemophilia community has been waiting for gene therapy for years; many hoped it would be a cure. Quantitative and qualitative results from late stages of clinical trials for...